Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Trump Media and Technology Group Corp (DJT) vs Ginkgo Bioworks Holdings Inc (DNA) Price & Performance

Trump Media and Technology Group CorpTrade
Ginkgo Bioworks Holdings IncTrade

Price performance (Past 24H)

Key statistics

Trump Media and Technology Group Corp vs Ginkgo Bioworks Holdings Inc — how do they compare? Trump Media and Technology Group Corp trades at $8.11 (market cap $2.28B), while Ginkgo Bioworks Holdings Inc trades at $13 (market cap $763.64M). The key difference: Trump Media and Technology Group Corp is far larger — about 3× Ginkgo Bioworks Holdings Inc's market cap, and Ginkgo Bioworks Holdings Inc is trading nearer its 52-week high, Trump Media and Technology Group Corp nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Trump Media and Technology Group Corp for 17 Days and Ginkgo Bioworks Holdings Inc for 7 Days on average.

DJTDNA
Market Cap
$2.28B$763.64M
Volume
3,148,3793,204,177
Sector
MediaHealth
52-Week High
$17.07$15.83
52-Week Low
$7.06$5.48
Typical Hold Time
17 Days7 Days
Enterprise Value
$2.35B$865.59M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Trump Media and Technology Group Corp

DJT trades at $8.11, down 1.34% with bearish technical signals. The company reported $3.68M revenue in 2025 but a net loss of $712M, with negative margins and cash flow challenges. Recent news highlights a proposed merger with TAE Technologies and ongoing volatility linked to political developments and strategic shifts.

Outlook remains high-risk due to persistent losses and speculative sentiment. The merger with TAE offers potential diversification into fusion energy, but profitability concerns and insider selling weigh on investor confidence. Key risks include execution hurdles and dependence on political narratives.

Ginkgo Bioworks Holdings Inc

Ginkgo Bioworks (DNA) trades at $11.34, down 1.13% on the day, with a bullish technical signal from moving averages. The company reported a net loss of $312.76 million on $170.16 million revenue for 2025, with negative cash flow. Recent news includes a $17.5 million ARPA-H subcontract for RNA medicine manufacturing, highlighting ongoing strategic initiatives despite financial challenges.

The outlook remains speculative given persistent losses and cash burn, though analyst consensus is divided. Key risks include execution on revenue growth and path to profitability. Upside depends on successful commercialization of its biotech platform and partnerships, but high volatility and fundamental weakness warrant caution for investors.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

DJT

No sentiment data available yet.

DNA
47% Buy53% Sell
Avg holding period · 7 Days

Top news

Latest headlines on both assets

About Trump Media and Technology Group Corp

Trump Media & Technology Group is a media firm rooted in social media and digital streaming. Its flagship product, Truth Social, provides a platform focused on free speech and open conversation.

Read more on DJT →

About Ginkgo Bioworks Holdings Inc

Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.

Read more on DNA →